comparemela.com

Latest Breaking News On - Atherosclerotic cardiovascular disease risk - Page 1 : comparemela.com

Clinical Quiz: Nonstatin Therapies for LDL-C Lowering in Special Populations

This clinical quiz will test your knowledge on management of LDL-C special populations with nonstatin therapies based on the ACC's 2022 expert clinical decision pathway.

Coll cardiolAmerican college of cardiologyConsensus decision pathwayNonstatin therapiesCholesterol loweringAtherosclerotic cardiovascular diseaseAmerican collegeAtherosclerotic cardiovascular disease riskCardiology solution set oversight committee

The key numbers to know for better heart health

Is your heart healthy? Here are the key metrics to keep track of to maintain a healthy heart.

United statesRob hastingsPooja swamyBig bearLoma linda university medical centerAmerican heart associationMedicine interventional cardiologyLoma linda universityAtherosclerotic cardiovascular disease riskHeart attackKey metricsPreventive measuresHigh blood pressureHeart healthCircle of health

New ACC Guidance on Nonstatin Therapies for LDL-C Lowering

The new guidance addresses the role of nonstatin therapies for lowering LDL-C, which were not addressed in the 2018 ACC/AHA guideline on management of cholesterol.

United statesDonald lloyd jonesAmerican college of cardiologyJournal of the american college cardiologyNational lipid associationNorthwestern university feinberg school of medicineAmerican collegeConsensus decision pathwayNonstatin therapiesCholesterol loweringAtherosclerotic cardiovascular disease riskNorthwestern universityFeinberg schoolNational lipidIpid managementClinical guidelines

vimarsana © 2020. All Rights Reserved.